1. Introduction {#sec0005}
===============

Constitutional indocyanine green (ICG) excretory defect is extremely rare. Only five reports of hepatectomy in patients with a constitutional ICG excretory defect have been published in the English language literature until 2017 ([Table 1](#tbl0005){ref-type="table"}) \[[@bib0005], [@bib0010], [@bib0015], [@bib0020], [@bib0025]\]. Loss of active ICG transport across the hepatic membrane is thought to be the cause of this disorder \[[@bib0030],[@bib0035]\]. Because of advances in preoperative assessment of liver function, liver resection is a relatively safe procedure. The indocyanine green retention rate at 15 min (ICGR15) is important for estimating hepatic functional reserve and selection of the appropriate surgical procedure before hepatectomy is performed. Because of the rarity of constitutional ICG excretory defect, its clinical features are not well understood. We report here evaluation and treatment of a patient with such a disorder. This work has been reported in line with the SCARE criteria \[[@bib0040]\].Table 1Previously reported cases of hepatectomy with constitutional indocyanine green excretory defect.Table 1AuthorYearAge/sexICG R15Child-Pugh gradeDiseasePreoperative liver functional evaluationHH15/LHL15OperationPostoperative complicationsHanazaki et al.200047/F59.8N.DCavernous hemangiomaGSA liver scintigraphy0.49/0.86Left lateral sectionectomynoneYamanaka et al.200161/M72AHCCGSA liver scintigraphy,liver biopsy0.54/0.94Partial hepatectomy (S8)noneKadono et al.200678/F79.3ABile duct cystadenocarcinomaGSA liver scintigraphy, AKBRN.D/0.96Left hepatectomynoneMaeda et al.200769/F83.8AHCCBTRnoneRight anterior sectionectomynoneAoki et al.201377/M77.1BHCCGSA liver scintigraphy0.53/0.89Left medial sectionectomy + resection of the ventral region of the anterior segmenthyperbilirubinemiaOur case　83/M76.2AHCCGSA liver scintigraphy0.482/0.931Partial hepatectomy (S4)none[^1]

2. Case presentation {#sec0010}
====================

An 83-year-old man was admitted to our hospital for evaluation and management of a symptomatic liver mass. His medical history included diffuse large B-cell lymphoma, which was treated with rituximab + pirarubicin + cyclophosphamide + vincristine + prednisone therapy at 81 years old, and had bladder cancer (resected at 67 years) on follow-up. After resection of the bladder cancer, no recurrence was detected for 16 years. Liver dynamic computed tomography (CT) showed a low-density mass in the segment (S) 4 area, measured 40 mm in diameter. The density of the tumor was well enhanced in the arterial phase and washed-out in the portal phase. ([Fig. 1](#fig0005){ref-type="fig"}a--d). The hepatobiliary phase of Gd-EOB-DTPA-MRI shows tumor nodules in the liver with low intensity ([Fig. 1](#fig0005){ref-type="fig"}e). On positron emission tomography (PET)-CT, the maximum standard uptake value of the tumor in S4 of the liver was 3.2 ([Fig. 1](#fig0005){ref-type="fig"}f). MRI and PET-CT confirmed a single liver tumor that was 40 mm in diameter and located in the S4 region. Liver metastasis of malignant lymphoma was suspected because of the patient's medical history. Therefore, we performed a liver biopsy preoperatively. The patient was diagnosed with hepatocellular carcinoma (HCC) based on the biopsy results and imaging findings.Fig. 1(a--d) Liver dynamic computed tomography (CT). (a) Plain CT, (b) arterial phase, (c) portal phase and (d) delayed phase (arrows). The tumor, located in the segment 4 of the liver, measured 40 mm in diameter. The density of the tumor was well enhanced in the arterial phase and washed-out in the portal phase. (e) The hepatobiliary phase of Gd-EOB-DTPA-MRI shows tumor nodules in the liver with low intensity in segment 4 (arrow). (f) Positron emission tomography-CT. The SUV max of the tumor in S4 of the liver is 3.2 (arrow).Fig. 1

Upon presentation, the patient was afebrile, had no history of weight loss, and his appetite was good. His height was 166 cm, body weight 72 kg, and BMI 26.12. He has no drinking history. In a preoperative indocyanine green (ICG) test, the ICGR15 was 76.2%. The total bilirubin level was 1.1 mg/dL and the direct bilirubin level was 0.2 mg/dL. The serum albumin level was 4.7 g/dL and prothrombin activity was 96.3%. The Child--Pugh (CP) score was 5 points, which indicated a grade of A. The degree of liver damage was equivalent to A in accordance with the scoring system of the Liver Cancer Study Group of Japan. [Table 2](#tbl0010){ref-type="table"} shows the patient's laboratory data on admission. The hepatic uptake ratio of ^99m^Tc-galactosyl human serum albumin (GSA) by liver scintigraphy (LHL15) was 0.931 and the heart uptake ratio (HH15) was 0.482. The maximal removal rate of ^99m^Tc-GSA (GSA-Rmax) was 0.874 mg/min. GSA-Rmax in the predicted residual liver (GSA-RL) was greater than 0.765 mg/min, which was within the range considered safe for surgical procedures.Table 2Laboratory data on the initial visit.Table 2WBC4100/μlAFP2 ng/mlRBC421/μlCA19-928.3 U/mlHb12.9 g/dlCEA5.2 ng/mlPlt15.6 μlPIVKA-II92 U/mlPT91.4%APTT29 secHBs-Ag(−)TP6.8 g/dlHBs-Ab(−)Alb4.7 g/dlHBc-Ab(−)BUN12 smg/dlHCV-Ab(−)Cre0.84 mg/dlNa143 mmol/lANA(−)K3.8 mmol/lAMA(−)Cl106 mmol/lAST32 U/lICG R1576.2ALT24 U/lALP311 U/l99mTc-GSALDH339 U/lLHL150.931T-Bil1.1 mg/dlHH150.482D-Bil0.2 mg/dlLHL/HH1.932γ-GTP46 U/lChE282 U/lGSA-Rmax　(mg/min)CRP0.032 mg/dlTotal0.874Anterior segment0.313Posterior segment0.267Lateral　segmental＋caudate lobe0.185Medial　segment0.109

Despite this finding, Child--Pugh classification and ^99m^Tc-GSA liver scintigraphy did not show any abnormal findings, and there was no background disease. Antibody against hepatitis C virus and hepatitis B virus surface antigen were negative. The serum anti-mitochondrial antibody and anti-nuclear antibody were negative. The serum tumor markers alpha-fetoprotein, carcinoembryonic antigen, and cancer antigen 19-9 were within the and normal range, but the protein level induced by vitamin K absence-II levels was increased (92 mg/dL). Therefore, we diagnosed constitutional ICG excretory defect with HCC and decided to perform radical surgery. Therefore, the patient underwent partial hepatectomy (S4). Pathologically, the tumor was diagnosed as moderately differentiated HCC ([Fig. 2](#fig0010){ref-type="fig"}a). There was expansion and bleeding of perisinusoidal cells and an atrophic hepatic cord in the background of liver tissue. Because of previous chemotherapy, the diagnosis of sinusoidal obstruction syndrome (SOS) of the liver was established ([Fig. 2](#fig0010){ref-type="fig"}b). After partial hepatectomy (S4), the postoperative course was uneventful and the patient was discharged on the 8th postoperative day. The patient remains in good general condition.Fig. 2Microscopic findings (hematoxylin--eosin staining, ×200). (a) Cancerous area and (b) non-cancerous area. Expansion of perisinusoidal cells and an atrophic hepatic cord in the background of liver tissue can be seen (arrow). Fatty changes were observed in some areas. (c) Manson trichrome staining (×200) shows that there is no fibrosis.Fig. 2

3. Discussion {#sec0015}
=============

Hepatectomy in cases of constitutional ICG excretory defect is exceedingly rare. Only five reports of hepatectomy with this defect have been reported. Among these cases, only three patients had HCC \[[@bib0010],[@bib0020],[@bib0025]\]. Two other cases showed cavernous hemangioma and biliary cystadenocarcinoma \[[@bib0005],[@bib0015]\]. All of the patients were Japanese. The postoperative course in these patients was uneventful, except for only one patient with liver cirrhosis who also suffered from hyperbilirubinemia \[[@bib0025]\].

To the best of our knowledge, constitutional ICG excretory defect has only been reported in Japan. The ICG test is not usually performed in countries other than Japan and this disorder does not show any clinical symptoms. Therefore, unless the ICG test is frequently carried out on a regular basis, this disorder will likely not be observed. In Japan, the ICG test is considered one of the most important preoperative factors for estimation of hepatic functional reserve \[[@bib0045], [@bib0050], [@bib0055]\]. For assessment of patient hepatic functional reserve, the ICGR15 is an important factor, but it was outside the normal range in our case. Because variability in ICG values depends on hepatic blood flow, parenchymal cellular function, and biliary excretion, ICGR15 values are not reliable in the case of jaundice, the presence of a port-systemic shunt, or an ICG excretory defect \[[@bib0060]\]. Therefore, there is a problem of determining what the next step should be for evaluating patients.

GSA liver scintigraphy has been hypothesized to be the best modality with which to evaluate hepatic functional reserve \[[@bib0020]\]. Because this agent binds to hepatocytes for a long period, the distribution of the functioning hepatocyte mass can be assessed by performing single-photon emission computed tomography with ^99m^Tc-GSA \[[@bib0065]\]. Significant correlations have been observed between ICGR15 and both LHL15 (a receptor index) and HH15 (an index of blood clearance) (12). GSA-Rmax, which is calculated by using a radiopharmacokinetic model, is also correlated with the severity of liver disease. There is a significant difference in GSA-Rmax between patients with chronic hepatitis and normal liver function \[[@bib0070]\]. GSA-Rmax is useful for selecting candidates for hepatectomy. Extended hepatectomies are high-risk surgical procedures in the case of low GSA-Rmax scores (\<0.35) \[[@bib0070]\]. GSA-RL should be maintained at greater than 0.15 to avoid postoperative hyperbilirubinemia or hepatic failure \[[@bib0075]\]. Aoki et al. reported that patients with Dubin--Johnson syndrome and an ICG excretory defect should be analyzed by GSA scintigraphy for safe and successful hepatectomy procedures \[[@bib0025]\]. GSA scintigraphy showed a more accurate hepatic functional reserve in our case, which is why we used it to evaluate the predictive score.

In our case, liver injury included histological changes as SOS may be correlated to administration of cyclophosphamide as side effect \[[@bib0080]\]. A correlation between ICGR15 values and SOS has been described \[[@bib0085],[@bib0090]\]. The cut-off point of the ICGR15 test that correlated with diagnosis of SOS was 8% \[[@bib0095]\]. Although the background of liver tissue was mild SOS pathologically, the ICG R15 value was extremely high. Furthermore, GSA-Rmax was within the normal range. We finally concluded that the high value of the ICGR15 was affected by constitutional ICG excretory defect rather than SOS.

4. Conclusion {#sec0020}
=============

In conclusion, constitutional ICG excretory defect is an extremely rare disorder. At present, the indications for surgery for this condition should be comprehensively considered. Findings of liver function tests, such as a general liver function test and GSA liver scintigraphy, are important for treating this disorder.
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[^1]: HCC:hepatocellular carcinoma, AKBR: arterial ketone body ratio, GSA: 99 mTc-galactosyl-human serum albumin, BTR: branched chain amino acid and tyrosine ratio, N.D: not described.
